Sage Therapeutics
SAGE
#7026
Rank
$0.54 B
Marketcap
$8.68
Share price
0.00%
Change (1 day)
8.50%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -$0.31 Billion USD

According to Sage Therapeutics 's latest financial reports the company's current earnings are $70.41 Million USD. In 2024 the company made an earning of -$0.41 Billion USD, an increase over its 2023 earnings that were of -$0.55 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.31 Billion-24.83%
2024 -$0.41 Billion-26.01%
2023 -$0.55 Billion1.63%
2022 -$0.54 Billion16.36%
2021 -$0.46 Billion-175.55%
2020 $0.60 B-189.1%
2019 -$0.69 Billion82.43%
2018 -$0.38 Billion38.04%
2017 -$0.28 Billion69.9%
2016 -$0.16 Billion68.25%
2015 -$94.5 Million179.48%
2014 -$33.82 Million84.98%
2013 -$18.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-$47.43 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
$35.65 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
$0.51 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-$58.01 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA